Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dendritic Cell Sarcoma, Interdigitating × relmacabtagene autoleucel × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Rituximab 2 Cyclophosphamide 2 zanubrutinib 1 venetoclax 1 relmacabtagene autoleucel 1 pirtobrutinib 1 pembrolizumab 1 pegfilgrastim 1 obinutuzumab 1 glofitamab 1 fludarabine 1 axicabtagene ciloleucel 1 Whole-Body Irradiation 1 Vincristine 1 Triamcinolone 1 Tacrolimus 1 Prednisolone 1 Mycophenolic Acid 1 Melphalan 1 Lenalidomide 1 Granulocyte Colony-Stimulating Factor 1 Doxorubicin 1 Dexrazoxane 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07326371 2026-01-08

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Ruijin Hospital

Phase 2 Not yet recruiting

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡